Expression of codon optimized genes in microbial systems: current industrial applications and perspectives by Claudia Elena et al.
MINI REVIEW ARTICLE
published: 04 February 2014
doi: 10.3389/fmicb.2014.00021
Expression of codon optimized genes in microbial systems:
current industrial applications and perspectives
Claudia Elena, Pablo Ravasi, María E. Castelli, Salvador Peirú and Hugo G. Menzella*
Genetic Engineering and Fermentation Technology, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario-Conicet, Rosario,
Argentina
Edited by:
Eduardo A. Ceccarelli, Universidad
Nacional de Rosario, Argentina
Reviewed by:
Blaine Pfeifer, The State University of




Hugo G. Menzella, Genetic
Engineering and Fermentation






The efﬁcient production of functional proteins in heterologous hosts is one of the major
bases of modern biotechnology. Unfortunately, many genes are difﬁcult to express
outside their original context. Due to their apparent “silent” nature, synonymous codon
substitutions have long been thought to be trivial. In recent years, this dogma has been
refuted by evidence that codon replacement can have a signiﬁcant impact on gene
expression levels and protein folding. In the past decade, considerable advances in
the speed and cost of gene synthesis have facilitated the complete redesign of entire
gene sequences, dramatically improving the likelihood of high protein expression. This
technology signiﬁcantly impacts the economic feasibility of microbial-based biotechnolog-
ical processes by, for example, increasing the volumetric productivities of recombinant
proteins or facilitating the redesign of novel biosynthetic routes for the production of
metabolites. This review discusses the current applications of this technology, particularly
those regarding the production of small molecules and industrially relevant recombinant
enzymes. Suggestions for future research and potential uses are provided as well.
Keywords: synthetic biology, gene design, codon optimization, strain engineering, microbial systems
INTRODUCTION
Microorganisms are at the core of the production of pharma-
ceuticals, industrial enzymes, and ﬁne chemicals. In many cases,
heterologous expression of genes is required to meet commercial-
level demands of target proteins and/or metabolites. In this
context, variation in codon usage is considered as one of themajor
factors affecting protein expression levels, since the presence of
rare codons can reduce the translation rate and induce translation
errors with a signiﬁcant impact on the economics of recombinant
microbe-based production processes (Ikemura, 1981; Gustafsson
et al., 2004). The generation of massive genome sequencing data
and cost-effective custom DNA synthesis are foundational tech-
nologies for synthetic biology, an emerging discipline that aims to
create novel organisms containing designer genetic circuits for the
production of drugs, industrial enzymes, biofuels, and chemicals
(Endy, 2005; McDaniel and Weiss, 2005; Heinemann and Panke,
2006; Leonard et al., 2008). These circuits are built from standard
biological parts, including vectors, promoters, ribosomal binding
sites (RBSs), transcriptional terminators, and other gene expres-
sion regulatory elements. These parts were initially borrowed from
nature and nowadays engineered, to adapt their performance to a
particular application, or combined to create sophisticated devices
(Shiue and Prather, 2012).
Over the past decade, synthetic biology has contributed to
signiﬁcantly reduce the cost of many products manufactured in
microbial systemswhere only one gene needs to be over-expressed.
Inmany cases, the production of a target protein can be boosted by
several orders of magnitude by replacing a native sequence with its
optimized counterpart (Gustafsson et al., 2004, 2012). This seem-
ingly simple adjustment is of remarkable importance, since many
of these products are now traded as commodities and thus there
is a continuous need to reduce manufacturing costs in order to
remain competitive in the global markets (Menzella, 2011). The
ambitious next step of synthetic biology is to further reduce the
cost and time involved in developing recombinant organisms by
using pre-assembled parts that provide stable, predictable protein
expression (Dellomonaco et al., 2010; Nielsen and Keasling, 2011).
So far, most of the progress made in synthetic biology
was achieved in Escherichia coli, a preferred host for the
production of recombinant proteins because it combines fast
growth rate, inexpensive fermentation media and well under-
stood genetics (Burgess-Brown et al., 2008; Welch et al., 2009;
Menzella, 2011). However, efforts have been recently expanded to
other hosts including Streptomyces species (Medema et al., 2011),
Corynebacterium glutamicum (Becker andWittmann, 2012), yeast
(Krivoruchko et al., 2011; Siddiqui et al., 2012; Furukawa and
Hohmann, 2013), and algae (Wang et al., 2012; Gimpel et al.,
2013). This expanded landscape seeks to take advantage of the nat-
ural capabilities to synthesize precursors and cofactors required
to produce a particular target, exploit secretion abilities, or uti-
lize natural tolerance to over-accumulated metabolites (Zhu et al.,
2012). In this review we summarize the current state of the tech-
nology for the expression of codon optimized genes in microbial
systems. Examples of its application for the production of small
molecules and recombinant enzymes of industrial interest are pre-
sented, and suggestions for future research and uses are provided.
GENE DESIGN
Choosing a gene for optimal expression requires selection from a
large number of sequences. For example, a protein with an aver-
age size of 30 kDa may, in theory, be encoded by 10100 possible
DNA sequences (Welch et al., 2009). Historically, two approaches
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have been used for codon optimization. The ﬁrst, designated “one
amino acid-one codon,”uses themost abundant codon of the host
to encode all occurrences of a given amino acid in the optimized
sequence (Fuglsang, 2003; Gao et al., 2004; Supek and Vlahovicek,
2004; Villalobos et al., 2006; Feng et al., 2010; Marlatt et al., 2010;
Wang et al., 2010). This simple strategy, the most popular in the
early days of gene synthesis technology, has a major drawback:
a strongly transcribed mRNA from a gene with this design will
contain a high concentration of a subset of codons, resulting in
an imbalance in the tRNA pool, which in turn may reduce growth
due to tRNA depletion (Gong et al., 2006; Villalobos et al., 2006).
The second approach, named “codon randomization,” uses
translation tables based on the frequency distribution of the
codons in an entire genome or a subset of highly expressed genes.
These tables attachweights to each codon, thus codons are assigned
randomly with a probability given by the weights (Kodumal et al.,
2004; Jayaraj et al., 2005; Menzella et al., 2005; Welch et al., 2009;
Wang et al., 2010). This strategy was shown to be superior and was
quickly adopted by the synthetic biology community. In addition
to improving the yield of the desired product, the“codon random-
ization” strategy offers many further advantages. For example,
ﬂexibility in codon selection facilitates gene design by avoiding:
(i) repetitive elements that may lead to gene deletions; (ii) inter-
nal RBSs, polyadenylation signals, or transcriptional terminators;
(iii) secondary mRNA structures (Luisi et al., 2013); and (iv) by
facilitating elimination of unwanted restriction sites to assist the
assembly of larger constructs (Villalobos et al., 2006). Several large-
scale systematic studies describing variations on this strategy have
been conducted in recent years to provide data on the effect of
sequence variables (Kudla et al., 2009; Welch et al., 2009; Allert
et al., 2010).
Besides codon optimization, other parameters need to be con-
sidered to design a gene for efﬁcient translation, including the
global GC content (Gustafsson, 2009), local context of a given
codon (Villalobos et al., 2006), the presence of mRNA sequence
motifs (Pertzev and Nicholson, 2006), and the sequence of the
region including the ﬁrst 10 codons (Goodman et al., 2013). Many
web-based free softwares, with features ranging from basic to
advanced, were created for gene design during the last decade.
Examples include: DNA Works (Hoover and Lubkowski, 2002),
GeMS (Jayaraj et al., 2005); Optimizer (Puigbo et al., 2007);
Synthetic Gene Designer (Wu et al., 2006); and Gene Designer
(Villalobos et al., 2006). Currently, the majority of synthetic DNA
suppliers (including GenScript, DNA2.0, GeneArt and Genewiz)
offer sequence optimization services using proprietary algorithms
at no additional cost.
PARTS AND VECTORS
The application of synthetic DNA technology in engineered
microorganisms is not restricted to redesigned genes. Classic
expression vectors widely used in strain engineering derive from
natural sources and were never optimized for robust production.
Recently, great interest has arisen in the systematic engineering and
standardization of gene expression parts such as promoters, trans-
lation initiation signals, transcriptional terminators, selectable
markers, and replication origins to allow fast and predictable
combination of these elements.
Some applications, such as metabolic engineering, require
optimal levels of each enzyme to maximize production. This is
typically achieved by modulating gene expression by, for exam-
ple, varying transcription or translation levels. Synthetic biology
can offer collections of promoters and RBSs capable of provid-
ing different levels of gene expression for this purpose (Boyle
and Silver, 2012; Meng et al., 2013; Vogl et al., 2013). So far,
most of the available promoters have been taken from the nat-
ural sequences driving the expression of highly expressed genes.
Typical examples are the widely used AOX promoter from Pichia
pastoris (Tschopp et al., 1987) for yeast and the bacteriophage T7
promoter for E. coli (Studier and Moffatt, 1986), which provide
high transcription levels. Nowadays, synthetic promoter libraries
for tunable gene expression are available formany industrially rele-
vant microorganisms including E. coli (Wu et al., 2013), P. pastoris
(Hartner et al., 2008; Ruth et al., 2010; Vogl et al., 2013), C. glu-
tamicum (Yim et al., 2013), and Bacillus subtilis (Hansen et al.,
2009). Likewise, synthetic RBSs can be used to regulate gene
expression (Basu et al., 2005; Pﬂeger et al., 2006). Furthermore
a novel method for automatic design of artiﬁcial RBSs to control
gene expression has been recently described, expanding the tool-
box of artiﬁcial sequences to be used in custom genetic circuits
(Salis et al., 2009).
Despite current efforts, accurate predictions of the response
of any given promoter or RBS have often remained elusive. It
is possible that unknown interactions among isolated compo-
nents may signiﬁcantly affect the optimal level of gene expression
needed to achieve a particular ﬂux through a biosynthetic pathway
(Keasling, 2012). In a recent work, Kosuri et al. (2013) provided
an alternative strategy to screen the behavior of gene expres-
sion regulatory elements. They synthesized 12,563 combinations
of common promoters and RBSs and simultaneously measured
DNA, RNA, and protein levels from the entire library. They found
that RNA and protein expression were within twofold of expected
levels 80 and 64% of the time, respectively, and that the worst
5% of constructs deviated from prediction by 13-fold on aver-
age, which could hinder large-scale genetic engineering projects.
This comprehensive study provides a means to test standard
part combinations to optimize production of a particular target
molecule.
Genes are usually introduced into production microorganisms
using plasmid vectors (Figure 1). Synthetic biology provides the
means to speed up this process by using designer plasmid vectors,
where all the components are synthesized with standard formats
to facilitate exchange and testing of parts, as well as the assembly
of multi-gene constructs (Leonard et al., 2008; Shetty et al., 2008).
Several designs for the construction of synthetic plasmids and for
the assembly of parts have been proposed (Menzella et al., 2005,
2007; Reisinger et al., 2006; Shetty et al., 2008; Sarrion-Perdigones
et al., 2011). Themost popular format among the synthetic biology
community was created by Knight and co-workers (Shetty et al.,
2011). They proposed the BioBrick standard, where all parts are
ﬂanked by a common set of restriction sites that allow the join-
ing, combination, and rapid assembly of genetic parts to create
functional gene expression units.
So far, most of the work to create synthetic vectors reported
in the literature has been done in E. coli. Recently, we created a
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FIGURE 1 | Schematic representation of a synthetic biology network applied to the design of novel bio-based parts and devices, as well as to the
engineering of existing natural biological systems for the development of target products.
plasmid-based platform for the rapid engineering of C. glutam-
icum, a microorganism of great industrial interest. The approach
uses reporter genes to examine and classify promoters and RBSs
and permits the easy assembly of operons and genes clusters for
co-expression of heterologous genes to facilitate metabolic engi-
neering. Similarly, Constante and co-workers described a platform
to engineer eukaryotic hosts by using the BioBrick principle.
Interestingly, the system contains a variety of novel parts and
implements a recombinase-mediated DNA insertion, allowing
chromosomal site-directed exchange of genes in eukaryotic cell
lines (Constante et al., 2011).
PRACTICAL APPLICATIONS
The list of products obtained by the expression of codon
optimized genes in microorganisms is constantly growing and
includes biofuels, pharmaceuticals, novel bio-based materials and
chemicals, industrial enzymes, amino acids, and other metabolites
(Table 1).
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Table 1 | Expression of redesigned genes of industrial interest in microbial systems.
Application Product Host Titer Reference
Biofuels Short-chain alcohols
Isopropanol E. coli 4.9–13.6 g/L Hanai et al. (2007)
Butanol E. coli 1.2 g/L Inui et al. (2008)
E. coli 4 g/L Bond-Watts et al. (2011)
Fatty acid derivatives
C12–C18 fatty acid ethyl esters E. coli 700 mg/L Steen et al. (2010)
Isoprenoids
Bisabolene E. coli/S. cerevisae >900 mg/L Peralta-Yahya et al. (2011)
Biopolymers Polyhydroxybutyrate S. cerevisiae 180 mg/L Kocharin et al. (2013)
Chemical precursors Methyl halides S. cerevisiae 860 mg/L Bayer et al. (2009)
Industrial enzymes Cellulases S. cerevisae NR(∗) Heinzelman et al. (2009)
Phytases A. orizae NR(∗) Lichtenberg et al. (2011)
P. pastoris 12.2 g/L Xiong et al. (2006)
Cutinases P. pastoris NR(∗) Liu et al. (2009)
Lignocelluases P. pastoris 1–6 g/L Mellitzer et al. (2012)
Lipases P. pastoris 4 g/L Chang et al. (2006)
Prochimosin E. coli 20 g/L(∗∗) Menzella (2011)
Steryl glycosidase E. coli NR(∗) Aguirre et al. (2013)
Metabolites L-amino acids C. glutamicum 30–100 g/L Becker andWittmann (2012)
Therapeutics Artemisinic acid S. cerevisae 25 g/L Paddon et al. (2013)
Polyketide precursors E. coli Up to 90 mg/L Menzella et al. (2007, 2010)
Multiepitope antigenic proteins E. coli NR(∗) Talha et al. (2010), de Souza et al. (2013)
(∗) Not Reported; (∗∗) Inclusion bodies.
Production of novel biofuels is one of themost attractive appli-
cations for synthetic biology. Fuels like ethanol, biodiesel, butanol,
and terpenoid compounds are currently produced using engi-
neered microbes (Table 1). In fact, the main obstacle for the
production of these molecules at commercial level is the devel-
opment of robust microbes and processes (Fischer et al., 2008).
Synthetic biology provides tools to achieve optimal expression
of pathway genes to ensure the efﬁcient conversion of feedstock
materials to target molecules, which is critical to the success of
any metabolic engineering strategy. There has been consider-
able progress recently in the production of different biofuels, and
some of the processes have reached promising yields. Hanai and
co-workers combined enzymes from Clostridium acetobutylicum
(Thl, CtfAB, andADC),Clostridium beijerinckii (ADH), and E. coli
(AtoAD) to assemble a fermentative pathway inE. coli that resulted
in production of isopropanol at titers ranging from 4.9 to 13.6 g/L
(Hanai et al., 2007). Butanol production was achieved in E. coli
using the biosynthetic pathway from C. acetobutylicum and other
related clostridial species, reaching titers up to 1.2 g/L (Inui et al.,
2008). This was further improved to more than 4 g/L of butanol
production by replacing enzymes that are naturally reversible
with those that drive the reaction toward butanol formation,
expressed from codon optimized genes from different bacterial
species (Bond-Watts et al., 2011).
Fatty acid derivatives are other promising biofuel candidates,
due to their high energy density and low water solubility. Stenn
et al. engineered E. coli to produce C12–C18 fatty acid ethyl esters
(FAEEs) directly from glucose at a titer of∼700 mg/L (Steen et al.,
2010). Five engineering strategies were combined to achieve this
titer, including the elimination of the β-oxidation pathway and
the expression of several synthetic genes from different microor-
ganisms. Monoterpene and sesquiterpene hydrocarbons such as
limonene, pinene, and farnesene, are isoprenoid compounds with
promising fuel applications that have been produced in E. coli and
S. cerevisiae. Expression in E. coli of a codon-optimized bisabolene
synthase from the ﬁr tree Abies grandis, in conjunction with the
introduction of an optimized heterologous mevalonate pathway,
resulted in sesquiterpene bisabolene production of 900 mg/L.
A S. cerevisiae strain that overproduces farnesyl pyrophosphate
also gave bisabolene titers higher than 900 mg/L using the same
bisabolene synthase (Peralta-Yahya et al., 2011). The mevalonate
pathway expression was further improved in E. coli by intro-
ducing codon-optimized versions of the mevalonate kinase and
phosphomevalonate kinase genes after they were identiﬁed as
potential pathway bottlenecks (Redding-Johanson et al., 2011).
Codon optimized genes have been extensively used to produce
pharmaceuticals in microbial platforms. Polyketides are a class of
natural products with a high number of well-established clinical
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applications. The development of a variety of methods for polyke-
tide synthases (PKS) engineering (Menzella and Reeves, 2007;
Peiru et al., 2009, 2010) led to a pioneer synthetic biology project
conducted at Kosan Biosciences. The goal was to obtain polyke-
tide precursors for the synthesis of novel drugs. First, a generic
design for type I PKS genes was created to enable easy assem-
bly and expression of chimeric enzymes (Kodumal et al., 2004;
Menzella et al., 2005). The sequences of the synthetic genes were
then redesigned with custom made software to optimize codon
usage in order to maximize expression in E. coli and provide a
standard set of restriction sites to allow combinatorial assembly
into unnatural enzymes. Next, more than three million bases
of PKS genes were tested to validate the platform. These efforts
produced a variety of novel valuable compounds (Menzella et al.,
2007; Menzella et al., 2010).
Another remarkable contribution of synthetic biology is the
microbial production of artemisinin, a sesquiterpene endoperox-
ide used to treat malaria (Paddon et al., 2013). This compound
is naturally produced by the plant Artemisia annua, but the pro-
duction of plant-derived artemisinin is expensive; which limits its
access to many patients. Recently, Paddon and coworkers engi-
neered strains of S. cerevisiae for production of artemisinic acid,
a precursor of artemisinin by fermentation. The simultaneous co-
expression of synthetic genes provided an efﬁcient biosynthetic
route to artemisinic acid, with fermentation titers of 25 g/L.
Production of proteins for therapeutic use also takes advantage
of the use of synthetic genes; a comprehensive review describ-
ing progress in this ﬁeld has been recently published by Mitchell
(2011). An elegant synthetic biology approach was used to cre-
ate designer antigenic proteins for immunoassay-based diagnosis.
By designing synthetic genes encoding tandem combinations of
epitopes joined by ﬂexible peptide linkers, chimeric proteins
were obtained for the detection of antibodies in sera with higher
sensitivity and speciﬁcity (Talha et al., 2010; de Souza et al., 2013).
The global market for industrial enzymes exceeded $4 billion
in 2012 and is therefore an attractive target for cost reduction
using synthetic biology tools (Zhou et al., 2004; Menzella, 2011).
The use of codon optimized genes allowed notable increases
in the production of many enzymes in a variety of hosts,
including cellulases in S. cerevisiae (Heinzelman et al., 2009),
phytases in Aspergillus oryzae (Lichtenberg et al., 2011), cuti-
nases (Liu et al., 2009), lignocellulases (Mellitzer et al., 2012),
and lipases (Chang et al., 2006) in P. pastoris and calf prochy-
mosin in E. coli (Menzella, 2011). In the last example, a strain
developed in our laboratory harboring a codon optimized gene
produced 70% more prochymosin than that obtained with the
wild type sequence, with the concomitant reduction in production
costs.
In addition to the contribution to achieve more competitive
production processes, synthetic genes provide an attractive alter-
native for the discovery of enzymes for new applications. For
example, in order to search for thermostable enzymes to hydrolyze
steryl glucosides (major contaminants of oil-derived biodiesel), we
screened a library of archeal genes by retrieving the sequences in
silico, synthesizing codon optimized genes for expression in E. coli
and assessing their activity against the target. The approach was
very successful and resulted in excellent candidates for industrial
use (Aguirre et al., 2013). Other products of commercial interest
recently obtained from strains carrying codon optimized genes
include L-amino acids in C. glutamicum and E. coli (Becker and
Wittmann, 2012), and polyhydroxybutyrate and methyl halides in
S. cerevisiae (Bayer et al., 2009; Kocharin et al., 2013).
CONCLUSION AND FUTURE PERSPECTIVES
The beneﬁts of using codon optimized genes in industrial biotech-
nology have been extensively demonstrated during the past decade
and this technology is being rapidly adopted by strain develop-
ers in order to remain competitive in the current market. In
the examples presented here, just one or a few synthetic genes
need to be introduced into a host to generate novel products
or to dramatically reduce the cost of producing existing ones.
The cost of synthetic genes has been constantly decreasing dur-
ing the last decade; and technologies to assemble large fragments
of DNA and to make multiple simultaneous changes to wild
type genomes are becoming available (Montague et al., 2012).
Thus, we can envision a future where custom-made microorgan-
isms can be designed for a particular application (Gibson et al.,
2010).
One of the ﬁelds where these new technologies can make a
dramatic contribution is the production of commodity chemicals
in microbes. Initial steps toward this ambitious goal have already
been taken by industry. For example, an E. coli strain has been
engineered to produce 1,3-propanediol, where in addition to the
introduction of the pathway for the production of this target from
glycerol, several changes were made in the genome to increase the
ﬁnal yield (Nakamura andWhited, 2003).
Although tremendous progress has been made, in order to
fully harness the potential of synthetic biology we need a deeper
understanding of the underlying molecular principles of living
systems and further development of bioinformatic tools to assist
in the modeling of synthetic genomes behavior. These advances
are expected to arrive from the interactions amongmany scientiﬁc
disciplines.
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